Listar por autor "Cabezón, Marta"
Mostrando ítems 1-4 de 4
-
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
Malinverni, R.; Bargay, J.; Marcé, Silvia; Garrido, A.; Valcarcel Ferreiras, David; Cabezón, Marta; Xicoy, Blanca (BMC, 2021-01-14) -
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
MARCE, Silvia; Méndez, Aleix; Xicoy, Blanca; Estrada, Natalia; Cabezón, Marta; Sturla, Antonella Luciana; Cortes, Montse (MDPI, 2024-01-29) -
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib
Marcé, Silvia; García, Olga; Estrada, Natalia; Vélez, Patricia; Cortes, Montse; Cabezón, Marta; Xicoy, Blanca (MDPI, 2021-07-16) -
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
Estrada, Natalia; Beier, Fabian; García, Olga; Morales, Cristian; Boqué, Concepción; Sagüés-Serrano, Miquel; Ventura Ferreira, Monica; Vallansot, Rolando; Marcé, Silvia; Brümmendorf, Tim; Zamora, Lurdes; Cabezón, Marta; Xicoy, Blanca (Lippincott, Williams & Wilkins, 2021-11-30)